A detailed history of Sierra Summit Advisors LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Sierra Summit Advisors LLC holds 110,215 shares of BSX stock, worth $10.1 Million. This represents 2.12% of its overall portfolio holdings.

Number of Shares
110,215
Previous 147,030 25.04%
Holding current value
$10.1 Million
Previous $11.3 Billion 18.43%
% of portfolio
2.12%
Previous 2.81%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.96 - $84.0 $2.69 Million - $3.09 Million
-36,815 Reduced 25.04%
110,215 $9.24 Billion
Q2 2024

Aug 09, 2024

BUY
$67.33 - $77.71 $607,181 - $700,788
9,018 Added 6.53%
147,030 $11.3 Billion
Q1 2024

May 09, 2024

SELL
$57.6 - $68.62 $59,500 - $70,884
-1,033 Reduced 0.74%
138,012 $9.45 Billion
Q4 2023

Feb 22, 2024

BUY
$48.64 - $57.81 $6.76 Million - $8.04 Million
139,045 New
139,045 $8.04 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Sierra Summit Advisors LLC Portfolio

Follow Sierra Summit Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sierra Summit Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sierra Summit Advisors LLC with notifications on news.